Small molecule therapeutic - SCOHIA PHARMA
Alternative Names: Project C - SCOHIA PHARMALatest Information Update: 30 Aug 2023
At a glance
- Originator SCOHIA PHARMA
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Research Unspecified
Most Recent Events
- 23 Aug 2023 Small molecule therapeutic - SCOHIA PHARMA is available for licensing as of 23 Aug 2023. https://www.scohia.com/eng/sys/pipeline/
- 23 Aug 2023 Early research in Unspecified in Japan (unspecified route) (Scohia Pharma pipeline, August 2023)